We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · June 09, 2020

Clinical Outcomes of Older Patients With Acute Myeloid Leukemia Receiving Hypomethylating Agents

Blood advances


Additional Info

Blood advances
Clinical Outcomes of Older Patients With AML Receiving Hypomethylating Agents: A Large Population-Based Study in the United States
Blood Adv 2020 May 26;4(10)2192-2201, AM Zeidan, R Wang, X Wang, RM Shallis, NA Podoltsev, JP Bewersdorf, SF Huntington, N Neparidze, S Giri, SD Gore, AJ Davidoff, X Ma

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading